OR WAIT null SECS
December 10, 2020
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 09, 2020
The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate.
CDMO HALIX will manufacture the drug substance for AstraZeneca’s COVID-19 vaccine candidate, AZD1222, at commercial scale at its cGMP facility in the Netherlands.
December 04, 2020
A longer-than-expected scale up of raw materials forces Pfizer to cut 2020 vaccine production in half.
December 03, 2020
The COVID-19 pandemic has accelerated the need for modular designs to rapidly expand vaccine production capacity.
December 02, 2020
The European Pharmacopoeia is preparing for 2021 while also supporting the industry to develop vaccines and treatments for COVID-19.
The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe.
December 01, 2020
Moderna has filed for authorization for its COVID-19 vaccine candidate, which has shown high efficacy and safety in a Phase III trial.
November 24, 2020
Wacker will support production of CureVac’s COVID-19 mRNA-based vaccine candidate at its biotech site in Amsterdam, with production scheduled to start in the first half of 2021.
The EC’s approval comes after positive results from seven Phase II and III randomized, active-controlled, multi-center studies.